Vinpocetine enhances cisplatin sensitivity of non-small cell lung cancer cells by reducing the nuclear factor erythroid 2-related factor 2 signaling
Qingyang Zhuang, Yunjian Huang, Yaping Hong, Wu Zhuang, Kai Zhu, Zhangzhou Huang
DOI: 10.1136/jim-2022-002369 Published 15 August 2022
Qingyang Zhuang
1
Department of Radiation Oncology, Fujian Cancer Hospital & Fujian Medical University Cancer Hospital, Fuzhou, Fujian, China
Yunjian Huang
2
Department of Thoracic Oncology, Fujian Cancer Hospital & Fujian Medical University Cancer Hospital, Fuzhou, Fujian, China
Yaping Hong
2
Department of Thoracic Oncology, Fujian Cancer Hospital & Fujian Medical University Cancer Hospital, Fuzhou, Fujian, China
Wu Zhuang
2
Department of Thoracic Oncology, Fujian Cancer Hospital & Fujian Medical University Cancer Hospital, Fuzhou, Fujian, China
Kai Zhu
2
Department of Thoracic Oncology, Fujian Cancer Hospital & Fujian Medical University Cancer Hospital, Fuzhou, Fujian, China
Zhangzhou Huang
2
Department of Thoracic Oncology, Fujian Cancer Hospital & Fujian Medical University Cancer Hospital, Fuzhou, Fujian, China

Submit a Response to This Article
No eLetters have been published for this article.
Vinpocetine enhances cisplatin sensitivity of non-small cell lung cancer cells by reducing the nuclear factor erythroid 2-related factor 2 signaling
Qingyang Zhuang, Yunjian Huang, Yaping Hong, Wu Zhuang, Kai Zhu, Zhangzhou Huang
Journal of Investigative Medicine Aug 2022, 70 (6) 1358-1364; DOI: 10.1136/jim-2022-002369

Vinpocetine enhances cisplatin sensitivity of non-small cell lung cancer cells by reducing the nuclear factor erythroid 2-related factor 2 signaling
Qingyang Zhuang, Yunjian Huang, Yaping Hong, Wu Zhuang, Kai Zhu, Zhangzhou Huang
Journal of Investigative Medicine Aug 2022, 70 (6) 1358-1364; DOI: 10.1136/jim-2022-002369
Vinpocetine enhances cisplatin sensitivity of non-small cell lung cancer cells by reducing the nuclear factor erythroid 2-related factor 2 signaling
Qingyang Zhuang, Yunjian Huang, Yaping Hong, Wu Zhuang, Kai Zhu, Zhangzhou Huang
Journal of Investigative Medicine Aug 2022, 70 (6) 1358-1364; DOI: 10.1136/jim-2022-002369